Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer
Mary E. Cooley(Dana-Farber Cancer Institute), Karen M. Emmons(University of Maryland, Baltimore), Paul J. Catalano(Computational Physics (United States)), Qian Wang(Army Medical University), Raphael Bueno(Brigham and Women's Hospital), Robert I. Haddad(Georgetown University), Bruce E. Johnson(Harvard University)
Cited by 47
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k